In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...
An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...
Pharmaceutical Technology on MSN3 天
A slow start for self-amplifying mRNA vaccines
A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.
A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.
At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...
Everest Medicines’ Nefecon achieved 167 million yuan in sales in just over a month after its launch, showing its future big ...
Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...
A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...
Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...
Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.
Volunteers are currently being sought in Japan, Canada, Australia and the UK for a clinical trial to develop the world's ...
The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...